Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Clinical Pharmacokinetics|March 7, 2000
Interaction potential and tolerability of the coadministration of cilostazol and aspirinS Mallikaarjun, W P Forbes, S L BramerJournal of Clinical Pharmacology|April 29, 1998
Pharmacokinetics of multiple-dose oral cilostazol in middle-age and elderly men and womenA Suri, W P Forbes, S L BramerClinical Pharmacokinetics|March 7, 2000
Cilostazol pharmacokinetics after single and multiple oral doses in healthy males and patients with intermittent claudication resulting from peripheral arterial diseaseS L Bramer, W P Forbes, S MallikaarjunJournal of Pharmaceutical and Biomedical Analysis|February 24, 2001
Determination of cilostazol and its metabolites in human urine by high performance liquid chromatographyP N Tata, C H Fu, S L BramerClinical Pharmacokinetics|January 1, 1997
Theophylline and warfarin interaction studies with grepafloxacinC Efthymiopoulos, S L Bramer, A Maroli, et al.Pharmaceutical Research|April 1, 1989
Biologic activity of 5'-deoxy-5-fluorouridine by rectal administrationS L Bramer, L C Gunnarsson, J L AuPharmaceutical Development and Technology|December 1, 1999
The preparation of soft gelatin capsules for a radioactive tracer studyM S Tesconi, S L Bramer, S H YalkowskyPharmaceutical Research|May 1, 1993
Absorption of 2',3'-dideoxyinosine from lower gastrointestinal tract in rats and kinetic evidence of different absorption rates in colon and rectumS L Bramer, M G Wientjes, J L AuCancer Chemotherapy and Pharmacology|January 1, 1988
Effect of uridine coadministration on 5'-deoxy-5-fluorouridine disposition in ratsJ L Au, M G Wientjes, S L BramerThe Journal of Pharmacology and Experimental Therapeutics|May 1, 1993
Gastrointestinal and hepatic first-pass elimination of 2',3'-dideoxyinosine in ratsS L Bramer, J L Au, M G WientjesPageof 3